About Inventys
Inventys is a company based in Mumbai (India) founded in 2005 by Deepak B Birewar. It operates as a Managed Services, and Direct-to-Consumer (D2C). Inventys has raised $64.34 million across 4 funding rounds from investors including Multi Organics, Plutus Wealth and India Inflection Opportunity Fund. The company has 218 employees as of October 13, 2025. Inventys offers products and services including Exclusive Manufacturing, CDMO Services, and Specialty Chemicals. Inventys operates in a competitive market with competitors including Viyash, Blue Jet Healthcare, Shogun Organics, Aparna Pharmaceuticals and Ami organics, among others.
- Headquarter Mumbai, India
- Employees 218 as on 13 Oct, 2025
- Founders Deepak B Birewar
- Stage Minicorn
-
Sectors
Chemicals & MaterialsHealthcare Industrial Goods & Manufacturing
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Inventys Research Company
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$6.96 M (USD)-53.61as on Mar 31, 2023
-
Net Profit
$-1.38 M (USD)-184.77as on Mar 31, 2023
-
EBITDA
$279.77 K (USD)-93.13as on Mar 31, 2023
-
Total Equity Funding
$64.34 M (USD)
in 4 rounds
-
Latest Funding Round
$29.49 M (USD), Series B
Apr 20, 2022
-
Investors
Multi Organics
& 9 more
-
Employee Count
218
as on Oct 13, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Inventys
Inventys offers a comprehensive portfolio of products and services, including Exclusive Manufacturing, CDMO Services, and Specialty Chemicals. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Exclusive chemical manufacturing is provided for unique customer needs.
CDMO services are offered for life sciences molecule advancement.
Specialty chemicals are produced for pharma and electronics industries.
Unlock access to complete
Unlock access to complete
Funding Insights of Inventys
Inventys has successfully raised a total of $64.34M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $29.49 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $29.5M
-
First Round
First Round
(15 Dec 2007)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Series B - Inventys | Valuation | Plutus Wealth Management , Pantomath Group |
|
| Apr, 2022 | Amount | Angel Round - Inventys | Valuation | Arpit Khandelwal , Arpit Khandelwal |
|
| Dec, 2008 | Amount | Seed - Inventys | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Inventys
Inventys has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Multi Organics, Plutus Wealth and India Inflection Opportunity Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed across multiple sectors.
|
Founded Year | Domain | Location | |
|
Investment services are provided to emerging pre-IPO enterprises.
|
Founded Year | Domain | Location | |
|
Leading manufacturer of speciality chemicals and advanced intermediates with global reach.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Inventys
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Inventys
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Inventys Comparisons
Competitors of Inventys
Inventys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viyash, Blue Jet Healthcare, Shogun Organics, Aparna Pharmaceuticals and Ami organics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
APIs and intermediates are manufactured by Viyash as a CDMO.
|
|
| domain | founded_year | HQ Location |
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
|
|
| domain | founded_year | HQ Location |
Contract manufacturer of chemicals used in household insecticide products
|
|
| domain | founded_year | HQ Location |
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO.
|
|
| domain | founded_year | HQ Location |
Advanced API intermediates are manufactured for pharmaceutical use.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Inventys
Frequently Asked Questions about Inventys
When was Inventys founded?
Inventys was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Where is Inventys located?
Inventys is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Is Inventys a funded company?
Inventys is a funded company, having raised a total of $64.34M across 4 funding rounds to date. The company's 1st funding round was a Seed of $43.55K, raised on Dec 15, 2007.
How many employees does Inventys have?
As of Oct 13, 2025, the latest employee count at Inventys is 218.
What is the annual revenue of Inventys?
Annual revenue of Inventys is $6.96M as on Mar 31, 2023.
What does Inventys do?
Inventys Research Company is engaged in providing exclusive manufacturing and CDMO services to innovators in life sciences, focusing on crop protection, pharmaceuticals, and specialty chemicals. Operations are supported by expertise in flow chemistry, green chemistry, and deep backward integration. Services are extended across sectors like healthcare and electronics with a commitment to sustainability and innovation. Manufacturing capacities are being expanded to position Inventys among Indias top specialty chemical producers.
Who are the top competitors of Inventys?
Inventys's top competitors include Viyash, Shogun Organics and Blue Jet Healthcare.
What products or services does Inventys offer?
Inventys offers Exclusive Manufacturing, CDMO Services, and Specialty Chemicals.
Who are Inventys's investors?
Inventys has 10 investors. Key investors include Multi Organics, Plutus Wealth, India Inflection Opportunity Fund, Arpit Khandelwal, and Arpit Khandelwal.
What is Inventys's valuation?
The valuation of Inventys is $249.61M as of Apr 2022.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.